Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To explore ABO blood group distribution and clinical characteristics in patients with COVID-19.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The clinical data of 187 patients with COVID-19 seen between January 20, 2020 and March 5, 2020 at the First Hospital of Changsha were retrospectively analyzed. The differences in the ABO blood group distribution between COVID-19 patients and the control group (1,991 cases) were analyzed. The relationship between blood type and clinical characteristics was analyzed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of the 187 patients with COVID-19, 69 had type A (36.90%), 63 had type B (33.69%), 41 had type O (21.92%), and 14 had type AB blood (7.49%). The proportion of patients with type A blood in the COVID-19 group was significantly higher than that in the control group (36.90% vs. 27.47%, <em>P</em> =0.006), while the proportion of patients with type O blood in the COVID-19 group was significantly lower than that in the control group (21.92% vs. 30.19%, <em>P</em>= 0.018). The risk of COVID-19 was higher for individuals with blood group A than for those with blood group O (OR = 1.849, 95% CI = 1.228-2.768, <em>P</em>= 0.003). The risk of COVID-19 was higher for patients with blood group A than for those with a blood group other than A (OR = 1.544, 95% CI = 1.122-2.104, <em>P</em>= 0.006). Patients with blood group O had a lower risk of COVID-19 than non-O blood group patients (OR = 0.649, 95% CI = 0.457-0.927, <em>P</em>= 0.018). The ABO blood group distribution was related to COVID-19 status.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Patients with blood group A had an increased risk for infection with SARS-CoV-2, whereas blood group O was associated with a decreased risk, indicating that certain ABO blood groups were correlated with SARS-CoV-2 susceptibility. Blood type was related to some clinical characteristics of patients with COVID-19.</p>
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between ABO blood - type distribution and the clinical characteristics of COVID - 19 patients. Specifically, the study aims to analyze the distribution of different ABO blood - types among COVID - 19 patients and compare the differences between these blood - types and the control group. In addition, the study also explores the association between different blood - types and the clinical manifestations of COVID - 19 patients.
### Research Background
Since December 2019, many cases of pneumonia caused by the novel coronavirus have been discovered in Wuhan, Hubei province, China. The World Health Organization (WHO) officially named this disease Coronavirus Disease 2019 (COVID - 19). As the epidemic spreads, cases have also emerged in many other regions. Studies have shown that certain blood - types are related to specific virus infections. Therefore, studying the relationship between ABO blood - types and COVID - 19 is helpful for understanding the susceptibility of different blood - type populations to SARS - CoV - 2.
### Research Methods
The research team retrospectively analyzed the clinical data of 187 COVID - 19 patients who visited Changsha First Hospital from January 20, 2020 to March 5, 2020. These patients were divided into four groups: A, B, O, and AB according to different ABO blood - types. The study compared the ABO blood - type distribution of these patients with that of the control group (1,991 non - COVID - 19 patients) and analyzed the relationship between different blood - types and clinical characteristics.
### Main Results
- **ABO Blood - type Distribution**:
- Among the 187 COVID - 19 patients, there were 69 patients with blood - type A (36.90%), 63 patients with blood - type B (33.69%), 41 patients with blood - type O (21.92%), and 14 patients with blood - type AB (7.49%).
- Compared with the control group, the proportion of blood - type A in COVID - 19 patients was significantly higher (36.90% vs. 27.47%, P = 0.006), while the proportion of blood - type O was significantly lower (21.92% vs. 30.19%, P = 0.018).
- **Risk Analysis**:
- The risk of COVID - 19 infection in patients with blood - type A was higher than that in patients with blood - type O (OR = 1.849, 95% CI = 1.228 - 2.768, P = 0.003).
- The risk of COVID - 19 infection in patients with blood - type A was also higher than that in non - blood - type A patients (OR = 1.544, 95% CI = 1.122 - 2.104, P = 0.006).
- The risk of COVID - 19 infection in patients with blood - type O was lower than that in non - blood - type O patients (OR = 0.649, 95% CI = 0.457 - 0.927, P = 0.018).
- **Clinical Characteristics**:
- There were significant differences in the symptom distribution of patients with different blood - types in terms of fever, cough, dyspnea, sore throat, and fatigue. For example, patients with blood - type A were more likely to have a fever (85.51%), while patients with blood - type O were less likely to have a fever (53.66%).
- Cough was more common in patients with blood - type A (71.01%) and less common in patients with blood - type O (43.90%).
- Dyspnea was less common in patients with blood - type A (42.03%) and more common in patients with blood - type AB (50.00%).
- Fatigue was more common in patients with blood - type A and blood - type O (blood - type A: 60.87%, blood - type O: 56.10%) and less common in patients with blood - type AB (14.29%).
### Conclusion
The research results show that patients with blood - type A have a higher risk of being infected with SARS - CoV - 2, while patients with blood - type O have a lower risk. This indicates that certain ABO blood - types are related to the susceptibility to SARS - CoV - 2. In addition, there are also significant differences in the clinical manifestations of patients with different blood - types, suggesting that blood - types may affect the clinical characteristics of COVID - 19 patients.
### Limitations
The limitations of the study include a relatively small sample size (only 187 patients), and there may be undiagnosed COVID - 19 patients in the control group. Therefore, the research results may have some biases. Nevertheless, the research results still provide valuable insights for understanding the relationship between ABO blood - types and COVID - 19.